Bridgeway Capital Management’s Medpace MEDP Stock Holding History

Bridgeway Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46M	Sell	2,750 -80	-3%	-$36.9K	0.03%	648
2026 Q1	$1.36M	Sell	2,830 -2,560	-47%	-$1.31M	0.03%	635
2025 Q4	$3.03M	Buy	+5,390	New	+$3.06M	0.06%	385
2024 Q4	–	Sell	-4,480	Closed	-$1.5M	–	1264
2024 Q3	$1.5M	Hold	4,480	–	–	0.03%	587
2024 Q2	$1.85M	Hold	4,480	–	–	0.04%	533
2024 Q1	$1.81M	Buy	+4,480	New	+$1.58M	0.04%	602
2022 Q4	–	Sell	-2,600	Closed	-$409K	–	1423
2022 Q3	$409K	Hold	2,600	–	–	0.01%	943
2022 Q2	$389K	Hold	2,600	–	–	0.01%	932
2022 Q1	$425K	Hold	2,600	–	–	0.01%	980
2021 Q4	$566K	Hold	2,600	–	–	0.01%	944
2021 Q3	$492K	Sell	2,600 -300	-10%	-$54.7K	0.01%	1034
2021 Q2	$512K	Hold	2,900	–	–	0.01%	1057
2021 Q1	$476K	Sell	2,900 -100	-3%	-$15.3K	0.01%	1096
2020 Q4	$418K	Hold	3,000	–	–	0.01%	1011
2020 Q3	$335K	Sell	3,000 -900	-23%	-$104K	0.01%	1025
2020 Q2	$363K	Buy	+3,900	New	+$332K	0.01%	969

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bridgeway Capital Management's MEDP Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Medpace (MEDP) stake by 2.8% in Q2 2026, selling an estimated $36.9K and leaving 2,750 shares worth $1.46M. The position accounts for 0.03% of the portfolio, ranked #648.

Bridgeway Capital Management first reported a position in MEDP in Q2 2020 and has held it in 16 quarters since. The position peaked at $3.03M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Bridgeway Capital Management held 2,750 shares of Medpace worth $1.46M as of Q2 2026.
Bridgeway Capital Management sold 80 Medpace shares in Q2 2026, an estimated $36.9K.
Medpace made up 0.03% of Bridgeway Capital Management's portfolio in Q2 2026, its #648 holding.
Bridgeway Capital Management first reported a position in Medpace in Q2 2020 and has held it in 16 quarters since.
Bridgeway Capital Management's Medpace position peaked at $3.03M in Q4 2025.
695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.